Lupus-related skin conditions are manifestations of autoimmune disease, where the immune system mistakenly attacks healthy skin tissue. These conditions include forms such as cutaneous lupus erythematosus, which can present as rashes, lesions, photosensitivity, and scarring, often affecting the face, scalp, and other sun-exposed areas.
Symptoms can vary in severity and may fluctuate with disease activity, commonly referred to as flare-ups. In addition to physical discomfort, visible skin involvement can significantly impact confidence and quality of life.
Managing lupus-related skin conditions can be challenging, as treatment often requires balancing immune suppression with long-term safety. While therapies such as topical agents, antimalarials, and immunomodulators are commonly used, not all patients achieve adequate or sustained control.
Clinical trials are essential in advancing new treatment options for lupus-related skin disease. At Rejuvenation Dermatology, our studies focus on evaluating innovative therapies that target immune pathways involved in inflammation and skin damage.
Participants receive access to investigational treatments in a controlled, medically supervised environment. Each trial follows strict ethical and regulatory standards, ensuring patient safety while contributing to the development of more effective and targeted therapies.
Our goal is to reduce disease activity, minimize flare-ups, protect skin integrity, and improve overall quality of life for individuals living with lupus-related skin conditions.
EVIDENCE DRIVES BETTER AUTOIMMUNE SKIN CARE
We believe lupus-related skin conditions require more than symptomatic treatment. Our clinical trials are designed to evaluate advanced therapies that target immune-mediated inflammation, generating meaningful data to improve long-term patient outcomes.
RESEARCH INTEGRATED INTO REAL CLINICAL PRACTICE
All studies are conducted within active dermatology clinics, allowing patients to receive care in a familiar and professional setting. Our dermatologists understand the complexity of autoimmune skin disease and tailor care accordingly.
ETHICS ARE NON-NEGOTIABLE
Every trial undergoes independent ethics board review before enrollment begins. Participants are fully informed, carefully screened, and continuously monitored, with safety protocols that meet and exceed regulatory standards.
STANDARDIZED, NATIONAL EXECUTION
Our multi-site research network operates under centralized oversight and standardized protocols, ensuring consistent study execution, high-quality data collection, and reliable outcomes across all locations.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
DERMATOLOGY-LED RESEARCH
Our trials are led by experienced dermatologists with expertise in autoimmune and inflammatory skin diseases. Physician oversight ensures every participant receives clinically sound, research-driven care.
EXPERTISE IN COMPLEX AUTOIMMUNE CONDITIONS
Lupus-related skin disease requires a nuanced approach. Our studies are designed to address varying disease presentations, including patients with persistent or treatment-resistant symptoms.
SAFETY FIRST, ALWAYS
Patient safety is central to every study. Strict eligibility criteria, continuous monitoring, and adherence to Good Clinical Practice guidelines ensure a safe and controlled research environment.
CONSISTENT EXECUTION, TRUSTED RESULTS
Sponsors rely on our ability to recruit efficiently and deliver high-quality, audit-ready data. This structured approach ensures a reliable and seamless experience for participants.
ADVANCING FUTURE LUPUS THERAPIES
Participation in clinical trials contributes to the development of new therapies that may improve long-term outcomes for individuals living with lupus-related skin conditions.
Yes, all studies follow strict medical and ethical guidelines.
Eligibility depends on the specific study but typically includes individuals with diagnosed or suspected cutaneous lupus.
These are skin manifestations of lupus, an autoimmune disease where the immune system attacks healthy tissue.
LUPUS-RELATED SKIN CONDITIONS CLINICAL TRIALS | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
